يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Frati P."', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 1
    Transcriptional Profiling of Melanoma Sentinel Nodes Identify Patients with Poor Outcome and Reveal an Association of CD30+ T Lymphocytes with Progression

    المؤلفون: Antonello Domenico Cabras, Paola Deho, Chiara Camisaschi, Monica Rodolfo, Barbara Vergani, Federica Crippa, Niccolò Bassani, Antonino Carbone, Roberto Patuzzo, Silvana Canevari, Paola Frati, Flavio Arienti, Mario Santinami, Loris De Cecco, Licia Rivoltini, Viviana Vallacchi, Elia Biganzoli, Federico Ambrogi, Chiara Castelli, Antonello Villa, Marialuisa Sensi, Elisabetta Vergani

    المساهمون: Vallacchi, V, Vergani, E, Camisaschi, C, Deho, P, Cabras, A, Sensi, M, De Cecco, L, Bassani, N, Ambrogi, F, Carbone, A, Crippa, F, Vergani, B, Frati, P, Arienti, F, Patuzzo, R, Villa, A, Biganzoli, E, Canevari, S, Santinami, M, Castelli, C, Rivoltini, L, Rodolfo, M

    المصدر: Cancer Research. 74:130-140

    مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, CD30, T-Lymphocytes, Population, Ki-1 Antigen, Antigens, CD30, Immune system, Biopsy, medicine, Humans, education, Melanoma, education.field_of_study, medicine.diagnostic_test, Sentinel Lymph Node Biopsy, business.industry, Computational Biology, FOXP3, Sentinel node, medicine.disease, Immunohistochemistry, Treatment Outcome, T-Lymphocyte, Oncology, Disease Progression, Transcriptome, business, CD8, Human

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbcb7f6591fe7358932f6317c679a3fdTest
    https://doi.org/10.1158/0008-5472.can-13-1672Test


    أضف إلى المفضلة
  2. 2
    Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I–Modified Peptides

    المؤلفون: Chiara Castelli, Marco Asioli, Paola Filipazzi, Claudia Lombardo, Michele Maio, Antonello Villa, Chiara Camisaschi, Riccardo Danielli, Gabrina Tragni, Gloria Sovena, Paola Frati, Gianluigi Rigamonti, Roberto Patuzzo, Licia Rivoltini, Paola Squarcina, Andrea Maurichi, Giorgio Parmiani, Agata Cova, Luigi Mariani, Felicetta Giardino, Annabella Di Florio, Lorenzo Pilla, Mario Santinami, Vanna Chiarion-Sileni

    المساهمون: Filipazzi, P, Pilla, L, Mariani, L, Patuzzo, R, Castelli, C, Camisaschi, C, Maurichi, A, Cova, A, Rigamonti, G, Giardino, F, Di Florio, A, Asioli, M, Frati, P, Sovena, G, Squarcina, P, Maio, M, Danielli, R, Chiarion Sileni, V, Villa, A, Lombardo, C, Tragni, G, Santinami, M, Parmiani, G, Rivoltini, L

    المصدر: Clinical Cancer Research. 18:6485-6496

    مصطلحات موضوعية: Cancer Research, T-Lymphocytes, medicine.medical_treatment, Epitopes, T-Lymphocyte, Human leukocyte antigen, Cross Reactions, Cancer Vaccines, MART-1 Antigen, Immune system, medicine, Humans, Melanoma, Neoplasm Staging, business.industry, Histocompatibility Antigens Class I, Cancer, tumor recognition, medicine.disease, Vaccination, Treatment Outcome, Oncology, Immunization, Case-Control Studies, Vaccines, Subunit, Immunology, Peptides, business, Immunologic Memory, Adjuvant, CD8

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3c5b9ae8349137943b5dd0914a43af7Test
    https://doi.org/10.1158/1078-0432.ccr-12-1516Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث